Nevro (NVRO)
(Delayed Data from NYSE)
$9.25 USD
-0.08 (-0.86%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $9.25 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Brokerage Reports
Nevro Corp. [NVRO]
Reports for Purchase
Showing records 1 - 20 ( 93 total )
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Optimized Entry and Exit Levels for NVRO 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Company: Nevro Corp.
Industry: Medical - Instruments
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department
Company: Nevro Corp.
Industry: Medical - Instruments
Company: Nevro Corp.
Industry: Medical - Instruments
Provider: Zacks Investment Research
Analyst: Research Department